929007-01-2

Upstream product

• 929006-91-7 (6S,7S)-6-(dibenzylamino)-2,2,13,13,14,14-hexamethyl-3,3-diphenyl-4,12-dioxa-3,13-disilapentadec-9-yn-7-ol 
• 929006-90-6 (2R,3S)-4-(tert-butyldiphenylsilyloxy)-1-chloro-3-(dibenzylamino)butan-2-ol 
• 929006-89-3 4-(tert-butyl-diphenyl-silanyloxy)-1-chloro-3-dibenzylamino-butan-2-one 
• 929006-76-8 (S)-N,N-dibenzyl-2-(tert-butyldiphenylsilyloxy)-1-((R)-oxiran-2-yl)ethanamine 
• 800391-48-4 3-(tert-butyl-diphenyl-silanyloxy)-2-dibenzylamino-propionaldehyde 
• 929006-77-9 4-((4S,5S)-5-(dibenzylamino)-2,2-dimethyl-1,3-dioxan-4-yl)but-2-yn-1-ol 
• 929006-79-1 (Z)-4-((4S,5S)-5-(dibenzylamino)-2,2-dimethyl-1,3-dioxan-4-yl)but-2-en-1-ol 
• 929006-92-8 (2S,3S)-2-(dibenzylamino)hept-5-yne-1,3,7-triol 
• 929006-98-4 ((2R,3S)-3-(((4S,5S)-5-(dibenzylamino)-2,2-dimethyl-1,3-dioxan-4-yl)methyl)oxiran-2-yl)methanol 

Relevant academic research and scientific papers

Asymmetric synthesis of diastereomeric diaminoheptanetetraols. A proposal for the configuration of (+)-zwittermicin A

A proposed absolute configuration for the 7 stereocenters in (+)-zwittermicin A is described based on asymmetric synthesis of six diastereomeric 2,6-diamino-1,3,5,7-heptanetetraols corresponding to the C9-C15 segment, pairwise 13C NMR chemical